相似文献
1
Human melanoma antigen AH is an autoantigenic ganglioside related to GD2.
J Exp Med. 1982 Dec 1;156(6):1884-9. doi: 10.1084/jem.156.6.1884.
2
Ganglioside GM2 as a human tumor antigen (OFA-I-1).
Proc Natl Acad Sci U S A. 1983 Sep;80(17):5392-6. doi: 10.1073/pnas.80.17.5392.
3
Human monoclonal antibody with dual GM2/GD2 specificity derived from an immunized melanoma patient.
Proc Natl Acad Sci U S A. 1990 May;87(9):3333-7. doi: 10.1073/pnas.87.9.3333.
4
Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines.
Cancer Res. 1989 Dec 1;49(23):6645-51.
5
Recombinant antibodies against ganglioside expressed on tumor cells.
Cancer Chemother Pharmacol. 2000;46 Suppl:S13-7. doi: 10.1007/pl00014042.
6
Human monoclonal antibody to ganglioside GD2-inhibited human melanoma xenograft.
Eur J Cancer Clin Oncol. 1984 Aug;20(8):1053-9. doi: 10.1016/0277-5379(84)90108-1.
7
Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients.
Proc Natl Acad Sci U S A. 1987 May;84(9):2911-5. doi: 10.1073/pnas.84.9.2911.
8
Human monoclonal antibody to tumor-associated ganglioside GD2.
J Clin Lab Immunol. 1984 Nov;15(3):119-26.
9
Ganglioside antigens in tissue sections of skin, naevi, and melanoma--implications for treatment of melanoma.
Cancer Treat Res. 1991;54:137-51. doi: 10.1007/978-1-4615-3938-4_8.
10
Human monoclonal antibody to tumor-associated ganglioside GD2: suppressed growth of human melanoma in nude mice.
Immunol Lett. 1984;8(4):169-74. doi: 10.1016/0165-2478(84)90072-5.
引用本文的文献
1
GD2 is a Crucial Ganglioside in the Signal Modulation and Application as a Target of Cancer Therapeutics.
Cancer Sci. 2025 Apr;116(4):862-870. doi: 10.1111/cas.70011. Epub 2025 Feb 7.
2
From antimicrobial to anticancer: the pioneering works of Prof. Luiz Rodolpho Travassos on bioactive peptides.
Braz J Microbiol. 2023 Dec;54(4):2561-2570. doi: 10.1007/s42770-023-01118-8. Epub 2023 Sep 19.
3
A limitless Brazilian scientist: Professor Travassos and his contribution to cancer biology.
Braz J Microbiol. 2023 Dec;54(4):2551-2560. doi: 10.1007/s42770-023-01085-0. Epub 2023 Aug 17.
4
Enhanced Levels of Glycosphingolipid GM3 Delay the Progression of Diabetic Nephropathy.
Int J Mol Sci. 2023 Jul 12;24(14):11355. doi: 10.3390/ijms241411355.
5
Epigenetic control of expression as a mechanism of resistance to immune checkpoint therapy in poorly immunogenic melanomas.
Front Immunol. 2023 Apr 3;14:1152228. doi: 10.3389/fimmu.2023.1152228. eCollection 2023.
6
Glycoconjugates: Synthesis, Functional Studies, and Therapeutic Developments.
Chem Rev. 2022 Oct 26;122(20):15603-15671. doi: 10.1021/acs.chemrev.1c01032. Epub 2022 Sep 29.
7
Signaling domains of cancer-associated glycolipids.
Glycoconj J. 2022 Apr;39(2):145-155. doi: 10.1007/s10719-022-10051-1. Epub 2022 Mar 22.
8
Anti-GD2 CAR T cells could prove transformative for H3-K27M diffuse midline gliomas.
Transl Cancer Res. 2019 Mar;8(Suppl 2):S87-S93. doi: 10.21037/tcr.2018.08.21.
9
Sphingolipid metabolism in the development and progression of cancer: one cancer's help is another's hindrance.
Mol Oncol. 2021 Dec;15(12):3256-3279. doi: 10.1002/1878-0261.13063. Epub 2021 Jul 29.
10
TNFα-signal and cAMP-mediated signals oppositely regulate melanoma- associated ganglioside GD3 synthase gene in human melanocytes.
Sci Rep. 2019 Oct 14;9(1):14740. doi: 10.1038/s41598-019-51333-3.
本文引用的文献
1
Lipid and protein alterations of spinal cord and cord myelin of multiple sclerosis.
J Neurochem. 1982 Aug;39(2):464-77. doi: 10.1111/j.1471-4159.1982.tb03968.x.
2
GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody.
J Exp Med. 1982 Apr 1;155(4):1133-47. doi: 10.1084/jem.155.4.1133.
3
Cancer immunology: the search for specificity--G. H. A. Clowes Memorial lecture.
Cancer Res. 1981 Feb;41(2):361-75.
4
Serological survey of normal humans for natural antibody to cell surface antigens of melanoma.
Proc Natl Acad Sci U S A. 1980 Jul;77(7):4260-4. doi: 10.1073/pnas.77.7.4260.
5
Preparation and properties of antibodies to GD3 and GM1 gangliosides.
J Neurochem. 1980 Jan;34(1):184-8. doi: 10.1111/j.1471-4159.1980.tb04638.x.
6
Oncofetal antigen-I: distribution in human tumors.
J Natl Cancer Inst. 1981 Sep;67(3):557-62.
7
Immunochemical studies on blood groups. LIV. Classification of anti-I and anti-i sera into groups based on reactivity patterns with various antigens related to the blood group A,B,H, Le a, Le b and precursor substances.
J Exp Med. 1972 Jun 1;135(6):1247-58. doi: 10.1084/jem.135.6.1247.
8
Anti-Pr3: serological and immunochemical identification of a new anti-Pr subspecificity.
Vox Sang. 1976;30(2):122-33. doi: 10.1111/j.1423-0410.1976.tb02802.x.
9
Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells.
Proc Natl Acad Sci U S A. 1976 Sep;73(9):3278-82. doi: 10.1073/pnas.73.9.3278.
10
Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens.
J Exp Med. 1976 Oct 1;144(4):873-81. doi: 10.1084/jem.144.4.873.
Zotero 插件